A Mindful Community for People With ALS and Their Primary Caregivers
NCT ID: NCT05595850
Last Updated: 2024-01-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
300 participants
INTERVENTIONAL
2023-10-12
2024-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The efficacy of mindfulness-based treatments for the improvement of QOL was previously demonstrated by the investigator's group. Despite preliminary positive results, treatment efficacy tends to weaken over time. The investigators believe that a robust solution to maintain efficacy is to maximize the utilization of technology and emerging social platforms, establishing a "mindful community" to promote and continuously reinforce mindfulness.
This project's primary aims are 1) to develop a "mindful" online community of people with ALS and their caregivers, and 2) to test its efficacy in QOL improvement. This two-part intervention consists of 1) optimizing the investigator's prior e-learning platform with a three-week program including cognitive exercises, videos and lectures to increase participants' mindfulness; and 2) involving participants in a "mindfulness community" within a social sharing forum. Assessments will be performed before and immediately post-treatment as well as 3- and 6-months post-program comparing subjects undergoing the intervention to a control group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Online Mindfulness Intervention for People With ALS and Their Caregivers
NCT03095989
Integrating Mindfulness Into the Patient-Centered Medical Home (Phase 3)
NCT03609450
Mindfulness-based Lifestyle Modification Programme for Caregivers of People With Neurodegenerative Disorders: A Pilot Randomised Controlled Trial
NCT06583018
Mindfulness-based Lifestyle Modification Programme for Caregivers of People With Neurological Disorders
NCT07342140
MINDFUL-PC: Integrating Mindfulness Into the Patient-Centered Medical Home
NCT02972203
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mindfulness
Three-week online mindfulness course followed by one-month social community online interaction.
Mindfulness
Online non-meditation mindfulness program
Mindful Learning
Three-week online mindful learning course followed by one-month social community online interaction
Mindful Learning
Online learning program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mindfulness
Online non-meditation mindfulness program
Mindful Learning
Online learning program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* a definite, probable, laboratory-supported, or possible ALS by revised El-Escorial criteria
* they must have the physical ability, with or without adaptive devices, to use a smartphone, a tablet, or a computer
* have access to the Internet.
For the caregivers
* be the person who resides with the ALS patient and is the major provider of unpaid care and assistance (typically, the spouse or another close relative)
* s/he must be able to use the application
* have access to the Internet.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Catholic University of the Sacred Heart
OTHER
Harvard University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ellen Langer
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ellen Langer, PhD
Role: PRINCIPAL_INVESTIGATOR
Harvard U
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Harvard University
Cambridge, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB20-0629
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.